Home/ Stocks/ RLAY

Relay Therapeutics, Inc. Common Stock

RLAY XNAS

$19.77 +0.15 (+0.75%) ▲ 15-min delayed

Open

$19.11

High

$19.84

Low

$18.68

Volume

2.32M

Market Cap

$4.30B

About Relay Therapeutics, Inc. Common Stock

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 192 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$3.00M	$-73,291,000	$-0.41
FY 2025	$15.36M	$-276,479,000	$-1.61
Q3 2025	$0	$-74,149,000	$-0.43
Q2 2025	$677.0K	$-70,375,000	$-0.41

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for RLAY yet. Check out our latest market news or earnings calendar.

Get RLAY Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Relay Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.